23 September 2015 - The 2015 PWC survey of the Australian medicines industry provides an important and timely insight into the challenges and opportunities confronting the Australian innovative medicines industry.

The survey, titled Challenges and Change: A report on the Australian Pharmaceutical Industry provides a snapshot of the health of the local industry and is a rolling scorecard on the economic, regulatory and reimbursement pressures the industry is facing.

Medicines Australia CEO Tim James said, “It’s a time of significant challenges for the local innovative medicines industry”.

“The PWC survey shows that our member companies are facing an increasingly difficult reimbursement process, along with the Federal Budget measures, leading to delayed access to some new medicines.”

For more details, go to: https://medicinesaustralia.com.au/media-release/2015-pwc-pharma-industry-survey-highlights-challenges-for-innovative-medicines-sector/